(Q45002264)

8 December 2017

In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium (English)

1 reference

8 December 2017

Sarifakioglu E

1

1 reference

8 December 2017

Seçkin D

series ordinal

2

1 reference

8 December 2017

Demirbilek M

series ordinal

3

1 reference

8 December 2017

Can F

series ordinal

4

1 reference

8 December 2017

22 August 2007

1 reference

Clinical and Experimental Dermatology

8 December 2017

1 reference

8 December 2017

32

1 reference

8 December 2017

6

1 reference

8 December 2017

675-679

1 reference

A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns

8 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

Antifungal drug resistance to azoles and polyenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

Evaluation of in vitro resistance in patients with onychomycosis who fail antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

In vitro activities of 10 antifungal drugs against 508 dermatophyte strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

Evaluation of in vitro susceptibility of dermatophytes to oral antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

Antifungal susceptibility testing. New technology and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

In vitro antifungal susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

New agents for the treatment of systemic fungal infections--current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02480.X

10.1111/J.1365-2230.2007.02480.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference